00000cam 2200000zi 4500 9.957671 CaOODSP 20260319150749 m o d f cr cn||||||||| 251125e202601##onc ob f000 0 eng d 9780660799032 (statement) 9780660799049 (summary) CaOODSP eng rda CaOODSP n-cn--- HP40-396/2025E-PDF HP40-396/2025-1E-PDF Updated guidance for use of rabies vaccine for pre-exposure prophylaxis (PrEP). Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, January 2026. ©2026 1 online resource (51 pages) + summary (5 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Directives mises à jour sur l'utilisation des vaccins contre la rage pour la prophylaxie préexposition (PPrE). "An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI)"--Cover. "Pub.: 250365"--Page 2 (summary). The publication file in PDF format has been replaced on 19 March 2026 as requested by the Public Health Agency of Canada. Includes bibliographical references (pages 45-51). Rabies Vaccination Government policy Canada. Rabies vaccines Government policy Canada. Public Health Agency of Canada, issuing body. Canada. National Advisory Committee on Immunization, issuing body. Directives mises à jour sur l'utilisation des vaccins contre la rage pour la prophylaxie préexposition (PPrE). (CaOODSP)9.957672 PDF 669 KB https://publications.gc.ca/collections/collection_2026/aspc-phac/HP40-396-2025-eng.pdf Statement PDF 212 KB https://publications.gc.ca/collections/collection_2026/aspc-phac/HP40-396-2025-1-eng.pdf Summary 250365